mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.003 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.004 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.004 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.005 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.005 |